Building a Business Case for New MNP Applications

20/20 OptimEyes Technologies has developed a nanoparticle technology that can improve treatments for patients. We are moving forward into clinical trials for glaucoma, but we know we can improve other disease treatments with our technology. During this internship, our intern will evaluate other potential therapies where we could use our platform technology and build a business case for the top 5 diseases so we can create prototypes for these and test them in the lab.

Faculty Supervisor:

Todd Hoare

Student:

Partner:

20/20 OptimEyes Technologies

Discipline:

Life Sciences

Sector:

Professional, scientific and technical services

University:

McMaster University

Program:

Business Strategy Internship

Current openings

Find the perfect opportunity to put your academic skills and knowledge into practice!

Find Projects